Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ: OABI )

4.825 +0.025 (+0.52%)
Streaming Delayed Price Updated: 9:56 AM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OmniAb, Inc. - Common Stock

< Previous 1 2 Next >
OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in November
From OmniAb, Inc.
Via Business Wire
OmniAb Appoints Steve Love to its Board of Directors
From OmniAb, Inc.
Via Business Wire
OmniAb Announces Agenda for its Research & Technology Virtual Event
From OmniAb, Inc.
Via Business Wire
7 of the Best Cheap Stocks to Buy Under $5 in October 2023
While the concept is incredibly risky, those who want to give their portfolio a jolt should consider these best cheap stocks. 
Via InvestorPlace
OmniAb to Hold Research & Technology Virtual Event on November 9
From OmniAb, Inc.
Via Business Wire
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
OmniAb to Participate in Two Investor Conferences in September
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb Announces the Passing of Director Sunil Patel
From OmniAb, Inc.
Via Business Wire
OmniAb to Report Second Quarter 2023 Financial Results on August 10
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
7 Stocks to Buy for 200% Returns This Year
These high return stock investments all have the potential to triple in 2023 based on Wall Street expectations. 
Via InvestorPlace
7 Stocks to Buy for Their Massive Upside Potential
While blue chips are relatively predictable, they’re also boring. For serious gains, you need to check out these stocks to buy now. 
Via InvestorPlace
OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo
From OmniAb, Inc.
Via Business Wire
Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
$1.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher on Monday after recording losses last week. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
OmniAb Reports First Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Report First Quarter 2023 Financial Results on May 11
From OmniAb, Inc.
Via Business Wire
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
Via InvestorPlace
OmniAb to Participate in Upcoming Investor Conferences in May
From OmniAb, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
Via Benzinga
OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
Via Benzinga
7 Biotech Stocks That Could Be the Next Big Thing
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough. 
Via InvestorPlace
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30
From OmniAb, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.